|
SLC30A5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.230800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.65989999999705E-05 |
| Normal-vs-Stage2 |
1.248410E-01 |
| Normal-vs-Stage3 |
7.851000E-01 |
| Normal-vs-Stage4 |
8.440400E-01 |
| Stage1-vs-Stage2 |
3.382800E-01 |
| Stage1-vs-Stage3 |
6.017700E-02 |
| Stage1-vs-Stage4 |
9.793800E-02 |
| Stage2-vs-Stage3 |
3.992000E-01 |
| Stage2-vs-Stage4 |
4.298200E-01 |
| Stage3-vs-Stage4 |
9.907800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.004200E-04 |
| Normal-vs-AfricanAmerican |
1.096030E-02 |
| Normal-vs-Asian |
3.441000E-01 |
| Caucasian-vs-AfricanAmerican |
9.455800E-01 |
| Caucasian-vs-Asian |
6.997600E-01 |
| AfricanAmerican-vs-Asian |
7.233600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.51586999999065E-05 |
| Normal-vs-Female |
9.249000E-01 |
| Male-vs-Female |
9.52859999999722E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.547900E-02 |
| Normal-vs-Extreme_Weight |
4.44330000000104E-05 |
| Normal-vs-Obese |
5.676200E-02 |
| Normal-vs-Extreme_Obese |
2.339200E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.552400E-01 |
| Normal_Weight-vs-Obese |
6.387600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.980000E-01 |
| Extreme_Weight-vs-Obese |
6.092400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.697800E-01 |
| Obese-vs-Extreme_Obese |
2.268800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.849400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.184400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.66071999999629E-05 |
| Normal-vs-Age(81-100Yrs) |
2.040000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.063400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.180820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.439600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.056200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.323000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.693200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.80422999999097E-05 |
| Normal-VS-Type2 PRCC |
6.397700E-02 |
| Normal-VS-KIRP CIMP |
5.473800E-01 |
| Normal-VS-Unclassified PRCC |
3.705200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.735600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.294360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.800200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.397000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.940200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.951000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.738180E-03 |
| Normal-vs-N1 |
7.748600E-01 |
| Normal-vs-N2 |
9.324400E-01 |
| N0-vs-N1 |
4.474000E-02 |
| N0-vs-N2 |
2.903400E-01 |
| N1-vs-N2 |
8.730000E-01 |
|
|
